-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 03/07/26 )
NAV
₹121.84
Last change
₹1.45 +0.01%
Fund Size (AUM)
8635.75 Cr
Performance
13.21% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 03/07/26
AUM
8635.75 Cr
Expense Ratio
1.52 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | 7.93% | 20.62% | 13.21% |
| BSE Healthcare TR INR | 11.4% | 24.07% | 14.02% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.35% |
Lupin Ltd |
7.31% |
Dr Reddy's Laboratories Ltd |
6.72% |
Cipla Ltd |
6.16% |
Divi's Laboratories Ltd |
5.8% |
Apollo Hospitals Enterprise Ltd |
5.2% |
Mankind Pharma Ltd |
3.94% |
Medplus Health Services Ltd |
3.68% |
Sai Life Sciences Ltd |
3.43% |
Ajanta Pharma Ltd |
3.21% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
UTI Healthcare Fund
Equity healthcare-
Returns
-
14.43% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
14.43% (5Y)
-
-
UTI Healthcare IDCW-R Fund
Equity healthcare-
Returns
-
14.43% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
15.96% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
15.31% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
16.4% (5Y)
-
